Bio Essence Corp. Files 8-K for Material Agreement
Ticker: BIOE · Form: 8-K · Filed: Apr 4, 2024 · CIK: 1723059
| Field | Detail |
|---|---|
| Company | Bio Essence CORP (BIOE) |
| Form Type | 8-K |
| Filed Date | Apr 4, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $400,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k
TL;DR
Bio Essence Corp. signed a big deal, details TBD.
AI Summary
Bio Essence Corp. filed an 8-K on April 4, 2024, to report a material definitive agreement. The filing does not provide specific details about the agreement, parties involved, or any associated dollar amounts or dates beyond the filing date itself.
Why It Matters
This filing indicates Bio Essence Corp. has entered into a significant agreement, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — The lack of specific details in the 8-K regarding the material definitive agreement introduces uncertainty about its nature and potential impact.
Key Players & Entities
- Bio Essence Corp. (company) — Registrant
- April 4, 2024 (date) — Filing Date
- California (jurisdiction) — State of Incorporation
- Irvine, CA (location) — Principal Executive Offices
FAQ
What is the nature of the material definitive agreement Bio Essence Corp. entered into?
The 8-K filing does not specify the nature of the material definitive agreement.
Who are the parties involved in this material definitive agreement?
The filing does not disclose the names of the parties to the agreement.
Are there any financial terms or dollar amounts associated with this agreement mentioned in the filing?
No specific financial terms or dollar amounts related to the agreement are provided in this 8-K filing.
When was the material definitive agreement entered into?
The filing states the report is current as of April 4, 2024, but does not specify the exact date the agreement was entered into.
What is the principal business of Bio Essence Corp.?
Bio Essence Corp. is classified under the Pharmaceutical Preparations industry (SIC code 2834).
Filing Stats: 492 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-04-04 16:29:57
Key Financial Figures
- $400,000 — mount of Four Hundred Thousand Dollars ($400,000). The transaction closed on April 1, 20
Filing Documents
- ea0203327-8k_bio.htm (8-K) — 32KB
- ea020332701ex99-1_bio.htm (EX-99.1) — 73KB
- 0001213900-24-030435.txt ( ) — 285KB
- bioe-20240404.xsd (EX-101.SCH) — 3KB
- bioe-20240404_lab.xml (EX-101.LAB) — 33KB
- bioe-20240404_pre.xml (EX-101.PRE) — 22KB
- ea0203327-8k_bio_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Consent of Board of Directors (and Exhibit) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO ESSENCE CORP. /s/ Yin Yan By: Yin Yan Its: Chief Executive Officer Dated: April 4, 2024 2